Indoloquinazolines are a class of heterocyclic compounds that feature the combination of an indole ring and a quinazoline ring in their molecular structure. These compounds exhibit significant pharmaceutical interest due to their potential as therapeutic agents, particularly in treating various diseases such as cancer. The unique chemical properties of indoloquinazolines, including their ability to modulate multiple cellular targets, make them promising candidates for the development of multi-targeted drugs. Their structural complexity and diverse functional groups enable chemists to tailor these molecules for specific biological activities through medicinal chemistry approaches. Furthermore, studies have demonstrated that certain indoloquinazoline derivatives possess potent antiproliferative effects against various cancer cell lines, highlighting their potential in anti-tumor therapy. The continued exploration of indoloquinazolines is expected to lead to the discovery and development of novel therapeutic agents with improved pharmacological properties.